SELLAS Life Sciences (SLS) Gross Profit (2012 - 2022)

SELLAS Life Sciences (SLS) has 7 years of Gross Profit data on file, last reported at $900000.0 in Q1 2022.

• Gross Profit for Q1 2022 came in at $900000.0, down 83.93% year-over-year; the trailing twelve-month figure through Dec 2022 was $900000.0 (down 87.84% YoY), and the FY2022 annual result was $900000.0, down 87.84% from the prior year.
• Gross Profit slipped to $900000.0 in Q1 2022 per SLS's latest filing, from $1.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $5.6 million in Q1 2021 and troughed at $900000.0 in Q1 2022.
• A 3-year average of $2.6 million and a median of $1.8 million in 2020 frame the typical range for Gross Profit.
• On a YoY basis, Gross Profit climbed as much as 83.93% in 2022 and fell as far as 83.93% in 2022.
• A 3-year view of Gross Profit shows it stood at $1.9 million in 2020, then retreated by 5.26% to $1.8 million in 2021, then sank by 50.0% to $900000.0 in 2022.
• Business Quant data shows SLS's Gross Profit at $900000.0 in Q1 2022, $1.8 million in Q2 2021, and $5.6 million in Q1 2021.